And here's Morgan's rating it as an outweigh...snatch it cheap...

And here's Morgan's rating it as an outweigh...

snatch it cheap now or sit tight for big growth

Imexhs Limited (A$1.65) SPEC BUY TP A$2.73
Democratising imaging technology
IME is a next generation cloud-based medical imaging solution for healthcare organisations. Its affordable and multimodal enterprise solution enables for a whole-of-hospital approach and accessible by markets which are underserved by the large global providers. Recent regulatory approvals in US and Brazil has opened up further opportunities with a recent capital injection now allowing an acceleration into larger global markets. IME trades at a significant discount to peers which we believe will reduce as further contracts ex-LATAM are won and the company approaches profitability. Company guidance suggests a continuation of contracted revenue growth and profitability on the near-term horizon. We continue to remain overweight in the medical imaging thematic with strong tailwinds and shift to technologies which allow a whole of hospital approach. We initiate coverage on IME with a Speculative Buy recommendation and price target of A$2.73. Click here for more...